Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 7Thoracic 1Sarcoma 1Other neoplasm 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Melanoma 49Carcinoma, Basal Cell 12Neoplasm Metastasis 9Lymphoma, T-Cell, Cutaneous 9Skin Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Squamous Cell Carcinoma of Head and Neck 5Neoplasms 5Lymphoma, T-Cell 5Colorectal Neoplasms 5Carcinoma, Merkel Cell 5Uveal Melanoma 4Uterine Cervical Neoplasms 4Mycosis Fungoides 4Lymphoma 4Lung Neoplasms 4Carcinoma, Renal Cell 4Urinary Bladder Neoplasms 3Sarcoma 3Lymphoma, Non-Hodgkin 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Follicular 3Keratosis, Actinic 3Endometrial Neoplasms 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2Sezary Syndrome 2Prostatic Neoplasms 2

Interventions

Drug Therapy 2pembrolizumab 1motexafin gadolinium 1cobimetinib 1cabozantinib 1Vemurafenib 1Specimen Handling 1Ritonavir 1Radiotherapy 1Quality of Life 1Patient Reported Outcome Measures 1Observation 1Nivolumab 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1Indinavir 1Immunotherapy 1Doxorubicin 1Biopsy 1Biological Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Laryngeal Neoplasms × Biopsy × Dermatologic × Clear all
NCT05136196 2026-06-05

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

National Cancer Institute (NCI)

Phase 2 Recruiting
150 enrolled
DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Melanoma, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡